Literature DB >> 8376927

Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse.

S K Stanley1, J M McCune, H Kaneshima, J S Justement, M Sullivan, E Boone, M Baseler, J Adelsberger, M Bonyhadi, J Orenstein.   

Abstract

Infection with the human immunodeficiency virus (HIV) results in immunosuppression and depletion of circulating CD4+ T cells. Since the thymus is the primary organ in which T cells mature it is of interest to examine the effects of HIV infection in this tissue. HIV infection has been demonstrated in the thymuses of infected individuals and thymocytes have been previously demonstrated to be susceptible to HIV infection both in vivo, using the SCID-hu mouse, and in vitro. The present study sought to determine which subsets of thymocytes were infected in the SCID-hu mouse model and to evaluate HIV-related alterations in the thymic microenvironment. Using two different primary HIV isolates, infection was found in CD4+/CD8+ double positive thymocytes as well as in both the CD4+ and CD8+ single positive subsets of thymocytes. The kinetics of infection and resulting viral burden differed among the three thymocyte subsets and depended on which HIV isolate was used for infection. Thymic epithelial (TE) cells were also shown to endocytose virus and to often contain copious amounts of viral RNA in the cytoplasm by in situ hybridization, although productive infection of these cells could not be definitively shown. Furthermore, degenerating TE cells were observed even without detection of HIV in the degenerating cells. Two striking morphologic patterns of infection were seen, involving either predominantly thymocyte infection and depletion, or TE cell involvement with detectable cytoplasmic viral RNA and/or TE cell toxicity. Thus, a variety of cells in the human thymus is susceptible to HIV infection, and infection with HIV results in a marked disruption of the thymic microenvironment leading to depletion of thymocytes and degeneration of TE cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376927      PMCID: PMC2191215          DOI: 10.1084/jem.178.4.1151

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  39 in total

1.  Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow.

Authors:  T M Folks; S W Kessler; J M Orenstein; J S Justement; E S Jaffe; A S Fauci
Journal:  Science       Date:  1988-11-11       Impact factor: 47.728

2.  Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone.

Authors:  K A Clouse; D Powell; I Washington; G Poli; K Strebel; W Farrar; P Barstad; J Kovacs; A S Fauci; T M Folks
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

Review 3.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

Authors:  A S Fauci
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

4.  Human immunodeficiency virus and papovavirus infections in acquired immunodeficiency syndrome: an ultrastructural study of three cases.

Authors:  J M Orenstein; F Jannotta
Journal:  Hum Pathol       Date:  1988-03       Impact factor: 3.466

5.  Monoclonal antibodies to the human immunodeficiency virus p18 protein cross-react with normal human tissues.

Authors:  C L Parravicini; D Klatzmann; P Jaffray; G Costanzi; J C Gluckman
Journal:  AIDS       Date:  1988-06       Impact factor: 4.177

6.  Infection of the SCID-hu mouse by HIV-1.

Authors:  R Namikawa; H Kaneshima; M Lieberman; I L Weissman; J M McCune
Journal:  Science       Date:  1988-12-23       Impact factor: 47.728

7.  The SCID-hu mouse as a model for HIV-1 infection.

Authors:  G M Aldrovandi; G Feuer; L Gao; B Jamieson; M Kristeva; I S Chen; J A Zack
Journal:  Nature       Date:  1993-06-24       Impact factor: 49.962

8.  The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function.

Authors:  J M McCune; R Namikawa; H Kaneshima; L D Shultz; M Lieberman; I L Weissman
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

9.  Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

Authors:  Y Koyanagi; S Miles; R T Mitsuyasu; J E Merrill; H V Vinters; I S Chen
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

10.  Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome.

Authors:  H Golding; F A Robey; F T Gates; W Linder; P R Beining; T Hoffman; B Golding
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  86 in total

1.  R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus.

Authors:  R D Berkowitz; A B van't Wout; N A Kootstra; M E Moreno; V D Linquist-Stepps; C Bare; C A Stoddart; H Schuitemaker; J M McCune
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Functional reconstitution of thymopoiesis after human immunodeficiency virus infection.

Authors:  S G Kitchen; S Killian; J V Giorgi; J A Zack
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv mice.

Authors:  C A Stoddart; M E Moreno; V D Linquist-Stepps; C Bare; M R Bogan; A Gobbi; R W Buckheit; J Bedard; R F Rando; J M McCune
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

4.  Expression and functional activity of CXCR-4 and CCR-5 chemokine receptors in human thymocytes.

Authors:  R Zamarchi; P Allavena; A Borsetti; L Stievano; V Tosello; N Marcato; G Esposito; V Roni; C Paganin; G Bianchi; F Titti; P Verani; G Gerosa; A Amadori
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

5.  Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes: differentiation from a CD4-positive precursor allows productive infection.

Authors:  S G Kitchen; C H Uittenbogaart; J A Zack
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  Interferons mediate terminal differentiation of human cortical thymic epithelial cells.

Authors:  Pierre-Olivier Vidalain; David Laine; Yona Zaffran; Olga Azocar; Christine Servet-Delprat; T Fabian Wild; Chantal Rabourdin-Combe; Hélène Valentin
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.

Authors:  S Resino; I Galán; A Pérez; J A León; E Seoane; D Gurbindo; M Angeles Muñoz-Fernandez
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

8.  Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse.

Authors:  H Kaneshima; L Su; M L Bonyhadi; R I Connor; D D Ho; J M McCune
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity.

Authors:  B D Jamieson; G M Aldrovandi; V Planelles; J B Jowett; L Gao; L M Bloch; I S Chen; J A Zack
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

Review 10.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.